Journalists are welcome
Time: 9 am-6 pm on Friday 28 May
Venue: Nobel Forum, Nobels väg 1, Karolinska Institutet Solna Campus, Stockholm
Caffeine is by far and away the world’s most widespread psychoactive stimulant. At least 70% of the adult population consumes caffeine every day – be it in coffee, tea, energy drinks or other food and drink – in such quantities that it affects the body in some way. The health benefits of caffeine that are now increasingly being supported by research include effects on cognitive ability among the elderly, as well as on Parkinson’s, type 2 diabetes and Alzheimer’s.
New results from population studies and basic research on the effects and mechanisms of caffeine will be presented at the Nobel mini-symposium.
There has been some concern that consuming caffeine during pregnancy can have a negative impact on the unborn child, and that it constitutes a risk factor for cardiovascular disease.
“There are research results that suggest that the children of mothers who consumed caffeine during pregnancy can exhibit behavioural changes, in that they react more strongly than others to substances that stimulate the central nervous system,” says Bertil Fredholm, professor of pharmacology at Karolinska Institutet. “This is thought to be passed on to the following generation.
“But other studies have shown that caffeine can benefit the child as it reduces the risk of temporary pauses in breathing, or apnoeas, in premature babies. It’s important to discuss the pros and cons.”
Many of the leading international researchers in the field will be attending.
For further information, please contact:
Professor Bertil Fredholm, who is responsible for the scientific programme
Tel: +46 8 524 879 39 or +46 70 776 43 44
Sabina Bossi, press officer
Tel +46 8 524 860 66 or +46 70 614 60 66